Latest blog articles
-
About a year ago, this blog published my contribution “Let us not forget about EU fundamental rights,” which addressed the situation at the EU’s external borders. At the time, the decision of the ECtHR in the case of N.D and N.T v. Spain, was heavily criticised for failing to protect the right to...
-
Simone Veil passed away on 30 June 2017, just two weeks shy of her 90th birthday. The fact that her funeral was a national ceremony at the Hȏtel des Invalides, and that her remains have been interred in the Panthéon - as one of the four women who have been bestowed with this honour because of their...
-
How do we guarantee access to COVID-19 vaccines and therapies, and secure health-related human rights for all? We’ve heard a string of promises in the race for new vaccines and therapies.
-
It’s been almost a month since the COVID-19 pandemic has drastically changed the way we live and work. Now that we are more used to, in a manner of speaking, the extraordinary measures to curtail the rampant spread of the virus, it’s time to seriously consider, and openly discuss, this crisis’...
-
Human rights violations continue to be a major issue at the EU’s external borders and pushbacks have been reported in several EU Member States. Most recently, the spotlight has been on Spain’s long-standing practice of pushbacks at the border of Melilla, as the ECtHR handed down its long-awaited...
-
In European societies, Female Genital Mutilation/Cutting FGM/C is regarded as an alien cultural practice that should not be part of society. It is seen as a barbaric tradition that is associated with refugees and immigrants from African and Muslim States who have brought this custom to Europe.
-
The Istanbul Convention certainly has the potential to improve the protection and support of battered women. However, much will depend on the implementation by the States parties and the interpretation and assessment of the obligations by the monitoring body.
-
Globally the majority of health-related R&D is invested in medicines with substantial guaranteed returns, yet what is missing is extensive R&D targeted at diseases overwhelmingly prevalent in developing countries. This threatens long-term availability of medicines and treatment options for these...